SHOVLIN ROBERT J. 4
4 · NEOGENOMICS INC · Filed May 27, 2021
Insider Transaction Report
Form 4
SHOVLIN ROBERT J.
Chief Operating Officer
Transactions
- Exercise/Conversion
Common Stock
2021-05-25$8.03/sh+96,167$772,221→ 249,914 total - Exercise/Conversion
Common Stock
2021-05-25$19.60/sh+16,724$327,790→ 266,638 total - Exercise/Conversion
Common Stock
2021-05-25$28.33/sh+14,067$398,518→ 280,705 total - Sale
Common Stock
2021-05-25$39.31/sh−130,604$5,134,043→ 150,101 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-05-25−16,724→ 33,449 totalExercise: $19.60Exp: 2024-03-01→ Common Stock (16,724 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2021-05-25−14,067→ 42,204 totalExercise: $28.33Exp: 2027-03-02→ Common Stock (14,067 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2021-05-25−96,167→ 0 totalExercise: $8.03Exp: 2023-02-26→ Common Stock (96,167 underlying)
Holdings
- 38,688
Stock Option (Right to Buy)
Exercise: $53.17Exp: 2028-03-02→ Common Stock (38,688 underlying)
Footnotes (4)
- [F1]On March 2, 2021, Mr. Shovlin was granted 38,688 stock options. These options vest ratably over the first four anniversary dates of the grant date
- [F2]On February 26, 2018, Mr. Shovlin was granted 288,500 stock options. These options vested ratably over the first three anniversary dates of the grant date.
- [F3]On March 1, 2019, Mr. Shovlin was granted 66,897 stock options. These options vest ratably over the first four anniversary dates of the grant date.
- [F4]On March 2, 2020, Mr. Shovlin was granted 56,271 stock options. These options vest ratably over the first four anniversary dates of the grant date.